The elevated enhancer of zeste homolog 2 (EZH2, an epigenetic regulator) in CD4+ T cells facilitated CXCR5+PD-1+ cTfh cell differentiation by enhancing STAT3 phosphorylation in SS patients (127). The gene discussed is EZH2; the disease is synovial sarcoma.